Director of the Institute
Antonio Lanzavecchia earned a degree in Medicine at the University of Pavia where he specialized in Paediatrics and in Infectious Diseases. From 1983 to 1999 he was a member of the Basel Institute for Immunology and since 1999 he is the founding director of the IRB in Bellinzona. He has been Professor of Immunology at the University of Genoa and at the University of Siena. From 2009 to 2016 has been professor of human immunology at the Federal Institute of Technology and since 2017 is Professor at the Faculty of Biomedical Sciences of the Università della Svizzera italiana (USI). Lanzavecchia received the EMBO Gold Medal and the Cloetta Prize and is a member of the EMBO, of the Swiss Academy of Medical Sciences and of the US National Academy of Sciences. In 2017, he also received the Robert Koch Prize and the Sanofi-Institut Pasteur Award and, in 2018 the Louis-Jeantet Prize for Medicine.
Dr. Lanzavecchia has published more than 310 papers. His research has covered several aspects of human immunology: antigen processing and presentation, dendritic cell biology, lymphocyte activation and traffic, T and B cell memory. Recently he developed a method for the efficient isolation of human monoclonal antibodies from memory B cells, which has been successfully applied to infectious diseases such as SARSCoV, H5N1, HCMV, Dengue, Malaria and HIV-1.
Research Group: Immune Regulation